CN115611797A - Asymmetric synthesis method of chiral gamma-indole-alpha-keto acid ester compound - Google Patents

Asymmetric synthesis method of chiral gamma-indole-alpha-keto acid ester compound Download PDF

Info

Publication number
CN115611797A
CN115611797A CN202211344626.5A CN202211344626A CN115611797A CN 115611797 A CN115611797 A CN 115611797A CN 202211344626 A CN202211344626 A CN 202211344626A CN 115611797 A CN115611797 A CN 115611797A
Authority
CN
China
Prior art keywords
gamma
indole
alpha
chiral
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202211344626.5A
Other languages
Chinese (zh)
Other versions
CN115611797B (en
Inventor
吕健
司雯
宋然
王满
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao University of Science and Technology
Original Assignee
Qingdao University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao University of Science and Technology filed Critical Qingdao University of Science and Technology
Priority to CN202211344626.5A priority Critical patent/CN115611797B/en
Publication of CN115611797A publication Critical patent/CN115611797A/en
Application granted granted Critical
Publication of CN115611797B publication Critical patent/CN115611797B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/22Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Catalysts (AREA)

Abstract

The invention discloses an asymmetric synthesis method of chiral gamma-indole-alpha-keto acid ester compounds, belonging to the field of organic synthesis. The method comprises the following steps: adding gamma-indole-beta, gamma-unsaturated-alpha-keto ester, hanster, lewis acid 1, lewis acid 2, chiral phosphoric acid, silver salt, additive and solvent into a reactor, and stirring at a certain temperature until the reaction is finished to selectively obtain one of two enantiomers of the chiral gamma-indole-alpha-keto ester compound. Wherein, gamma-indole-beta, gamma-unsaturated-alpha-keto ester, hans ester, lewis acid 1, chiral phosphoric acid, silver salt, additive and solvent are added to selectively obtain the compound with S configurationThe chiral gamma-indole-alpha-keto acid ester compound has the following reaction formula:
Figure DDA0003917886330000011
adding gamma-indole-beta, gamma-unsaturated-alpha-keto ester, hans ester, lewis acid 2, chiral phosphoric acid, additive and solvent to selectively obtain chiral gamma-indole-alpha-keto ester compounds with R configuration, wherein the reaction equation is as follows:

Description

Asymmetric synthesis method of chiral gamma-indole-alpha-keto acid ester compound
Technical Field
The invention discloses an asymmetric synthesis method of chiral gamma-indole-alpha-keto acid ester compounds, belonging to the technical field of organic synthesis.
Background
The chiral gamma-indole-alpha-keto acid ester compounds are important organic molecules, and both indole skeletons and keto ester skeletons in the molecules of the chiral gamma-indole-alpha-keto acid ester compounds are widely existed in natural products and bioactive molecules, so that the chiral gamma-indole-alpha-keto acid ester compounds have important research significance. The synthesis of the compounds can be realized by asymmetric reduction of carbon-carbon double bonds of gamma-indole-beta, gamma-unsaturated-alpha-keto ester.
Asymmetric reduction reaction of carbon-carbon double bond of unsaturated carbonyl compound is a very important reaction. This type of reaction utilizes the sp of the prochiral pair of negative hydrogens 2 And (3) performing addition on hybridized carbon atoms to realize the construction of a chiral center. This type of reaction can be achieved using amine-based catalysis (org.lett., 2009,11, 2756-2759), chiral ion-pair catalysis (j.am.chem.soc.2006, 128,13368-13369, angelw.chem.int.ed.2006, 45, 4193-4195) and like strategies. Chemists have successfully achieved the asymmetric reduction reaction of the carbon-carbon double bond of compounds such as gamma-substituted unsaturated aldehydes and ketones by using these strategies, but the above strategies are not applicable to gamma-indole-beta, gamma-unsaturated-alpha-keto esters with large steric hindrance at the gamma-position. Therefore, the realization of a novel selective synthesis method of the gamma-indole-alpha-keto acid ester compound has great significance for the research of the applicability range of the reaction.
Disclosure of Invention
The invention aims to overcome the problems of method limitation and enantioselectivity in the existing synthesis process of gamma-indole-alpha-keto ester compounds, and provides a method for selectively synthesizing two enantiomers of chiral gamma-indole-alpha-keto ester compounds by using different catalytic systems.
In order to achieve the above objects, the present invention provides an asymmetric synthesis method of a chiral γ -indole- α -keto acid ester compound, wherein the structural formulas of two enantiomers of the chiral γ -indole- α -keto acid ester compound have the structures shown in formula I and formula II, respectively:
Figure BDA0003917886310000021
the method comprises the following steps: adding gamma-indole-beta, gamma-unsaturated-alpha-keto ester, hanster, lewis acid 1, lewis acid 2, chiral phosphoric acid, silver salt, additive and solvent into a reactor, stirring at a certain temperature until the reaction is finished, concentrating the reaction liquid by a rotary evaporator to obtain a crude product, and performing column chromatography separation to obtain the product. Wherein, gamma-indole-beta, gamma-unsaturated-alpha-keto ester, hans ester, lewis acid 1, chiral phosphoric acid, silver salt, additive and solvent are added to selectively obtain the chiral gamma-indole-alpha-keto ester compound with S configuration, and the chemical process is shown in a reaction formula III:
Figure BDA0003917886310000022
adding gamma-indole-beta, gamma-unsaturated-alpha-keto ester, hans ester, lewis acid 2, chiral phosphoric acid, additive and solvent to selectively obtain a chiral gamma-indole-alpha-keto ester compound with R configuration, wherein the chemical process is shown in a reaction formula IV:
Figure BDA0003917886310000023
wherein R is selected from any one of phenyl, substituted phenyl and thienyl, and the substituent of the substituted phenyl is any one of halogen atom, saturated alkyl, alkoxy, phenyl and trifluoromethyl.
R 1 Selected from any one of hydrogen atom, halogen atom, saturated alkyl and alkoxy.
R 2 Is selected from any one of hydrogen atom, methyl and benzyl.
R 3 Is selected from any one of methyl, ethyl, isopropyl and benzyl.
R 4 Is selected from any one of methyl, ethyl, tertiary butyl and benzyl.
The Lewis acid 1 is any one selected from zirconium fluoride, zirconium chloride and zirconium bromide.
The Lewis acid 2 is selected from any one of ferric chloride, ferric bromide and ferric trifluoromethanesulfonate.
The silver salt is selected from any one of silver carbonate, silver acetate, silver trifluoroacetate, silver pentafluoropropionate, silver trifluoromethanesulfonate, silver tetrafluoroborate and silver hexafluorophosphate.
The additive is selected from
Figure BDA0003917886310000031
A molecular sieve,
Figure BDA0003917886310000032
Molecular sieve,
Figure BDA0003917886310000033
Any one of molecular sieves.
The chiral phosphoric acid has a structure shown in formula V and formula VI:
Figure BDA0003917886310000034
wherein Ar is 1 The compound is selected from substituted phenyl, and the substituent of the substituted phenyl is any one of phenyl, pentafluorophenyl and 1-naphthyl; ar (Ar) 2 Selected from biphenyl.
The solvent is any one of dichloromethane, 1, 2-dichloroethane, diethyl ether, tetrahydrofuran, 1, 4-dioxane, ethyl acetate, toluene and p-xylene.
The molar ratio of the gamma-indole-beta, gamma-unsaturated-alpha-keto ester, hans ester, lewis acid 1, lewis acid 2, chiral phosphoric acid and silver salt is 1.0 (1.0-2.0): 0-0.2): 0.05-0.2): 0-0.2; the dosage of the additive is 100-300mg/mmol.
The reaction time is 6-18h.
The reaction temperature is 0-60 ℃.
After the reaction, column chromatography separation is carried out by using a mixed solution of dichloromethane and petroleum ether.
The beneficial effects of the invention are as follows: the asymmetric synthesis method of the chiral gamma-indole-alpha-ketonic acid ester compound provided by the invention is scientific and reasonable, and can selectively synthesize two enantiomers of the chiral gamma-indole-alpha-ketonic acid ester compound; but also has the advantages of high yield, good enantioselectivity, wide substrate application range, simple operation, mild reaction, convenient post-treatment and the like.
Drawings
FIG. 1 is an NMR and high performance liquid chromatography spectrum of a compound (S-3 cc) prepared in example 5;
FIG. 2 is an NMR and high performance liquid chromatography spectrum of a compound (R-3 cc) prepared in example 6;
FIG. 3 is an NMR and high performance liquid chromatography spectrum of the compound (S-3 dd) prepared in example 7;
FIG. 4 is an NMR and HPLC spectrum of the compound (R-3 dd) prepared in example 8;
FIG. 5 is an NMR and high performance liquid chromatography spectrum of the compound (S-3 fa) produced in example 11;
FIG. 6 is an NMR and high performance liquid chromatography spectrum of the compound (R-3 fa) produced in example 12;
FIG. 7 is an NMR and high performance liquid chromatography spectrum of the compound (S-3 ha) prepared in example 15;
FIG. 8 is an NMR and high performance liquid chromatography spectrum of the compound (R-3 ha) prepared in example 16.
Detailed Description
The method of the present invention is described herein by way of examples, but the present invention is not limited thereto, and any modifications, equivalents, improvements, etc. within the technical spirit of the present invention should be included in the scope of the present invention.
Example 1:
the reaction equation is as follows:
Figure BDA0003917886310000051
compound 1a (5 mmol), 2a (7.5 mmol), zirconium chloride (0.5 mmol), chiral phosphoric acid (0.5 mmol), silver acetate (0.5 mmol) and
Figure BDA0003917886310000052
molecular sieves (1 g) were added to the reactor, and 100mL of methylene chloride was added thereto, followed by stirring at room temperature until the reaction was completed. After the reaction is finished, a crude product obtained by concentrating the reaction liquid by a rotary evaporator is separated by column chromatography by using a mixed solution of dichloromethane and petroleum ether with the volume ratio of 4.
Nuclear magnetic data for S-3aa are as follows:
1 H NMR(500MHz,CDCl 3 )δ7.53(d,J=8.0Hz,2H),7.48(t,J=8.0Hz,3H),7.40-7.37(m,4H),7.31-7.24(m,2H),7.18(t,J=7.0Hz,1H),7.03(t,J=7.5Hz,1H),6.89(s,1H),4.95(t,J=7.5Hz,1H),3.75(s,3H),3.71(s,3H),3.69-3.61(m,2H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.6,161.3,142.5,140.9,139.4,137.3,128.7,128.2,127.3,127.1,127.0,126.4,121.9,119.5,119.1,116.7,109.3,52.9,45.8,37.3,32.8ppm.
example 2
The reaction equation is as follows:
Figure BDA0003917886310000053
a mixture of compound 1a (5 mmol), 2a (7.5 mmol), ferric bromide (0.5 mmol), chiral phosphoric acid (0.5 mmol) and
Figure BDA0003917886310000061
molecular sieves (1 g) were added to the reactor, and 100mL of methylene chloride was added and the mixture was stirred at room temperature until the reaction was complete. After the reaction is finished, a crude product obtained by concentrating the reaction liquid by a rotary evaporator is separated by column chromatography by using a mixed solution of dichloromethane and petroleum ether with the volume ratio of 4.
Nuclear magnetic data for R-3aa are as follows:
1 H NMR(500MHz,CDCl 3 )δ7.53(d,J=8.0Hz,2H),7.48(t,J=8.0Hz,3H),7.40-7.37(m,4H),7.31-7.24(m,2H),7.18(t,J=7.0Hz,1H),7.03(t,J=7.5Hz,1H),6.89(s,1H),4.95(t,J=7.5Hz,1H),3.75(s,3H),3.71(s,3H),3.69-3.61(m,2H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.6,161.3,142.5,140.9,139.4,137.3,128.7,128.2,127.3,127.1,127.0,126.4,121.9,119.5,119.1,116.7,109.3,52.9,45.8,37.3,32.8ppm.
example 3
The reaction equation is as follows:
Figure BDA0003917886310000062
compound 1b (5 mmol), 2b (7.5 mmol), zirconium fluoride (0.5 mmol), chiral phosphoric acid (0.5 mmol), silver trifluoroacetate (0.5 mmol) and
Figure BDA0003917886310000063
molecular sieves (1 g) were charged into the reactor, and 100mL of 1, 2-dichloroethane was added and stirred at room temperature until the reaction was complete. After the reaction is finished, a crude product obtained by concentrating the reaction liquid by a rotary evaporator is subjected to column chromatography by using a mixed solution of dichloromethane and petroleum ether with the volume ratio of 4.
The nuclear magnetic data for S-3bb are as follows:
1 H NMR(500MHz,CDCl 3 )δ7.52(d,J=8.5Hz,2H),7.45(d,J=8.5Hz,2H),7.38(d,J=8.0Hz,1H),7.28(d,J=8.0Hz,1H),7.20(t,J=7.5Hz,1H),7.03(t,J=7.0Hz,1H),6.90(s,1H),4.97(t,J=7.5Hz,1H),3.79(s,3H),3.75(s,3H),3.69(dd,J=7.0,17.5Hz,1H),3.62(dd,J=8.0,17.5Hz,1H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.0,161.1,147.5,137.3,128.1,126.5,126.3,125.5,122.1,119.2,115.9,109.4,53.0,45.4,37.4,32.8ppm.
example 4
The reaction equation is as follows:
Figure BDA0003917886310000071
a mixture of compound 1b (5 mmol), 2b (7.5 mmol), ferric chloride (0.5 mmol), chiral phosphoric acid (0.5 mmol) and
Figure BDA0003917886310000072
molecular sieves (1 g) were charged into the reactor, and 100mL of 1, 2-dichloromethane was added thereto, followed by stirring at room temperature until the reaction was completed. After the reaction is finished, a crude product obtained by concentrating the reaction liquid by a rotary evaporator is subjected to column chromatography by using a mixed solution of dichloromethane and petroleum ether with the volume ratio of 4.
The nuclear magnetic data for R-3bb are as follows:
1 H NMR(500MHz,CDCl 3 )δ7.52(d,J=8.5Hz,2H),7.45(d,J=8.5Hz,2H),7.38(d,J=8.0Hz,1H),7.28(d,J=8.0Hz,1H),7.20(t,J=7.5Hz,1H),7.03(t,J=7.0Hz,1H),6.90(s,1H),4.97(t,J=7.5Hz,1H),3.79(s,3H),3.75(s,3H),3.69(dd,J=7.0,17.5Hz,1H),3.62(dd,J=8.0,17.5Hz,1H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.0,161.1,147.5,137.3,128.1,126.5,126.3,125.5,122.1,119.2,115.9,109.4,53.0,45.4,37.4,32.8ppm.
example 5
The reaction equation is as follows:
Figure BDA0003917886310000081
a mixture of compound 1c (5 mmol), 2c (7.5 mmol), zirconium bromide (0.5 mmol), chiral phosphoric acid (0.5 mmol), silver carbonate (0.5 mmol) and
Figure BDA0003917886310000082
molecular sieves (1 g) were added to the reactor, and 100mL of diethyl ether was added and stirred at room temperature until the reaction was complete. After the reaction is finished, concentrating the reaction solution by a rotary evaporator to obtain crude productThe product was separated by column chromatography using a mixed solution of dichloromethane and petroleum ether in a volume ratio of 4.
The nuclear magnetic data of S-3cc is as follows:
1 H NMR(500MHz,CDCl 3 )δ7.50(d,J=7.5Hz,1H),7.26(d,J=8.0Hz,1H),7.20(t,J=7.0Hz,1H),7.10(d,J=5.0Hz,1H),7.05(t,J=7.5Hz,1H),6.93-6.91(m,2H),6.88-6.87(m,1H),5.18(t,J=7.5Hz,1H),3.75(s,3H),3.71(s,3H),3.70-3.65(m,2H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.0,161.1,147.9,137.3,126.6,126.6,126.4,124.3,123.8,121.9,119.4,119.2,116.4,109.4,53.0,46.7,33.0,32.8ppm.
example 6
The reaction equation is as follows:
Figure BDA0003917886310000091
compound 1c (5 mmol), 2c (7.5 mmol), ferric triflate (0.5 mmol), chiral phosphoric acid (0.5 mmol) and
Figure BDA0003917886310000092
molecular sieves (1 g) were added to the reactor, and 100mL of diethyl ether was added thereto, followed by stirring at room temperature until the reaction was completed. After the reaction was completed, the crude product obtained by concentrating the reaction solution by a rotary evaporator was separated by column chromatography using a mixed solution of dichloromethane and petroleum ether in a volume ratio of 4.
The nuclear magnetic data for R-3cc is as follows:
1 H NMR(500MHz,CDCl 3 )δ7.50(d,J=7.5Hz,1H),7.26(d,J=8.0Hz,1H),7.20(t,J=7.0Hz,1H),7.10(d,J=5.0Hz,1H),7.05(t,J=7.5Hz,1H),6.93-6.91(m,2H),6.88-6.87(m,1H),5.18(t,J=7.5Hz,1H),3.75(s,3H),3.71(s,3H),3.70-3.65(m,2H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.0,161.1,147.9,137.3,126.6,126.6,126.4,124.3,123.8,121.9,119.4,119.2,116.4,109.4,53.0,46.7,33.0,32.8ppm.
example 7
The reaction equation is as follows:
Figure BDA0003917886310000093
a mixture of compound 1d (5 mmol), 2d (7.5 mmol), zirconium chloride (0.5 mmol), chiral phosphoric acid (0.5 mmol), silver pentafluoropropionate (0.5 mmol) and
Figure BDA0003917886310000101
molecular sieves (1 g) were added to the reactor, and 100mL of tetrahydrofuran was added thereto, followed by stirring at room temperature until the reaction was completed. After the reaction is finished, a crude product obtained by concentrating the reaction solution by a rotary evaporator is subjected to column chromatography separation by using a mixed solution of dichloromethane and petroleum ether with the volume ratio of 4.
The nuclear magnetic data for S-3dd are as follows:
1 H NMR(500MHz,CDCl 3 )δ7.33(d,J=7.5Hz,2H),7.26(t,J=7.0Hz,2H),7.21(s,1H),7.18-7.12(m,2H),7.02(t,J=7.5Hz,1H),7.00(d,J=8.5Hz,1H),6.80(s,1H),4.88(t,J=7.5Hz,1H),3.75(s,3H),3.68(s,3H),3.63-3.56(m,2H),2.38(s,3H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.7,161.4,143.4,135.8,128.5,128.2,127.8,127.0,126.5,126.5,123.5,119.0,116.2,109.0,52.9,45.9,37.7,32.8,21.5ppm.
example 8
The reaction equation is as follows:
Figure BDA0003917886310000102
a mixture of compound 1d (5 mmol), 2d (7.5 mmol), ferric bromide (0.5 mmol), chiral phosphoric acid (0.5 mmol) and
Figure BDA0003917886310000103
molecular sieve (1 g) was added to the reactor, and tetrahydrofuran (100 mL) was added thereto, followed by stirring at room temperature to reactAnd (6) ending. After the reaction is finished, a crude product obtained by concentrating the reaction liquid by a rotary evaporator is subjected to column chromatography separation by using a mixed solution of dichloromethane and petroleum ether with the volume ratio of 4.
Nuclear magnetic data for R-3dd are as follows:
1 H NMR(500MHz,CDCl 3 )δ7.33(d,J=7.5Hz,2H),7.26(t,J=7.0Hz,2H),7.21(s,1H),7.18-7.12(m,2H),7.02(t,J=7.5Hz,1H),7.00(d,J=8.5Hz,1H),6.80(s,1H),4.88(t,J=7.5Hz,1H),3.75(s,3H),3.68(s,3H),3.63-3.56(m,2H),2.38(s,3H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.7,161.4,143.4,135.8,128.5,128.2,127.8,127.0,126.5,126.5,123.5,119.0,116.2,109.0,52.9,45.9,37.7,32.8,21.5ppm.
example 9:
the reaction equation is as follows:
Figure BDA0003917886310000111
compound 1e (5 mmol), 2a (7.5 mmol), zirconium chloride (0.5 mmol), chiral phosphoric acid (0.5 mmol), silver triflate (0.5 mmol) and
Figure BDA0003917886310000112
molecular sieves (1 g) were added to the reactor, and 100mL of ethyl acetate was added thereto, followed by stirring at room temperature until the reaction was completed. After the reaction is finished, concentrating the reaction liquid by a rotary evaporator to obtain a crude product, and performing column chromatography separation by using a mixed solution of dichloromethane and petroleum ether in a volume ratio of 4.
The nuclear magnetic data for S-3ea are as follows:
1 H NMR(500MHz,CDCl 3 )δ7.44(s,1H),7.32(s,1H),7.28-7.25(m,4H),7.21-7.17(m,1H),6.90(s,1H),4.80(t,J=7.5Hz,1H),3.79(s,3H),3.66(s,3H),3.62(dd,J=7.5,17.0Hz,1H),3.55(dd,J=7.0,17.0Hz,1H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.2,161.2,142.7,136.2,128.7,128.1,127.6,126.9,126.5,125.9,123.2,120.4,116.6,110.9,53.0,45.6,37.3,33.0ppm.
example 10
The reaction equation is as follows:
Figure BDA0003917886310000121
a mixture of compound 1e (5 mmol), 2a (7.5 mmol), ferric bromide (0.5 mmol), chiral phosphoric acid (0.5 mmol) and
Figure BDA0003917886310000122
molecular sieves (1 g) were added to the reactor, and 100mL of ethyl acetate was added and the mixture was stirred at room temperature until the reaction was complete. After the reaction is finished, a crude product obtained by concentrating the reaction liquid by a rotary evaporator is subjected to column chromatography separation by using a mixed solution of dichloromethane and petroleum ether in a volume ratio of 4.
The nuclear magnetic data for R-3ea is as follows:
1 H NMR(500MHz,CDCl 3 )δ7.44(s,1H),7.32(s,1H),7.28-7.25(m,4H),7.21-7.17(m,1H),6.90(s,1H),4.80(t,J=7.5Hz,1H),3.79(s,3H),3.66(s,3H),3.62(dd,J=7.5,17.0Hz,1H),3.55(dd,J=7.0,17.0Hz,1H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.2,161.2,142.7,136.2,128.7,128.1,127.6,126.9,126.5,125.9,123.2,120.4,116.6,110.9,53.0,45.6,37.3,33.0ppm.
example 11
The reaction equation is as follows:
Figure BDA0003917886310000131
compound 1f (5 mmol), 2a (7.5 mmol), zirconium chloride (0.5 mmol), chiral phosphoric acid (0.5 mmol), silver tetrafluoroborate (0.5 mmol) and
Figure BDA0003917886310000133
molecular sieves (1 g) were charged to a reactor and toluene 1 was added00mL, stirring at room temperature until the reaction was complete. After the reaction is finished, a crude product obtained by concentrating the reaction liquid by a rotary evaporator is subjected to column chromatography separation by using a mixed solution of dichloromethane and petroleum ether in a volume ratio of 4.
The nuclear magnetic data for S-3fa are as follows:
1 H NMR(500MHz,CDCl 3 )δ8.06(s,1H),7.46(s,1H),7.40(d,J=8.0Hz,1H),7.34-7.30(m,2H),7.27(d,J=8.0Hz,1H),7.17(t,J=7.5Hz,1H),7.13(t,J=8.0Hz,1H),7.06-7.03(m,2H),4.88(t,J=7.5Hz,1H),3.79(s,3H),3.67(dd,J=7.5,17.5Hz,1H),3.56(dd,J=7.5,17.0Hz,1H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.1,161.2,145.7,136.6,130.8,130.1,129.8,126.6,122.7,122.5,121.5,119.7,119.2,117.6,111.2,53.0,45.5,37.3ppm.
example 12
The reaction equation is as follows:
Figure BDA0003917886310000132
the compound 1f (5 mmol), 2a (7.5 mmol), ferric bromide (0.5 mmol), chiral phosphoric acid (0.5 mmol) and
Figure BDA0003917886310000141
molecular sieves (1 g) were added to the reactor, and 100mL of toluene was added and stirred at room temperature until the reaction was complete. After the reaction is finished, a crude product obtained by concentrating the reaction liquid by a rotary evaporator is subjected to column chromatography by using a mixed solution of dichloromethane and petroleum ether with the volume ratio of 4.
The nuclear magnetic data for R-3fa is as follows:
1 H NMR(500MHz,CDCl 3 )δ8.06(s,1H),7.46(s,1H),7.40(d,J=8.0Hz,1H),7.34-7.30(m,2H),7.27(d,J=8.0Hz,1H),7.17(t,J=7.5Hz,1H),7.13(t,J=8.0Hz,1H),7.06-7.03(m,2H),4.88(t,J=7.5Hz,1H),3.79(s,3H),3.67(dd,J=7.5,17.5Hz,1H),3.56(dd,J=7.5,17.0Hz,1H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.1,161.2,145.7,136.6,130.8,130.1,129.8,126.6,122.7,122.5,121.5,119.7,119.2,117.6,111.2,53.0,45.5,37.3ppm.
example 13
The reaction equation is as follows:
Figure BDA0003917886310000142
1g (5 mmol) of the compound, 2a (7.5 mmol), zirconium chloride (0.5 mmol), chiral phosphoric acid (0.5 mmol), silver hexafluorophosphate (0.5 mmol) and
Figure BDA0003917886310000143
molecular sieves (1 g) were added to the reactor, p-xylene was added to the reactor in an amount of 100mL, and the mixture was stirred at 60 ℃ until the reaction was completed. After the reaction is finished, a crude product obtained by concentrating the reaction solution by a rotary evaporator is subjected to column chromatography by using a mixed solution of dichloromethane and petroleum ether in a volume ratio of 4.
Nuclear magnetic data for S-3ga are as follows:
1 H NMR(500MHz,CDCl 3 )δ7.42(d,J=8.0Hz,1H),7.32(d,J=7.5Hz,2H),7.29-7.24(m,5H),7.21-7.14(m,2H),7.11(t,J=7.5Hz,1H),7.06(d,J=7.5Hz,2H),7.00(t,J=7.5Hz,1H),6.97(s,1H),4.92(t,J=7.5Hz,1H),3.71(s,3H),3.73(s,3H),3.66(dd,J=7.5,17.5Hz,1H),3.59(dd,J=8.0,17.0Hz,1H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.6,161.4,143.3,137.6,137.0,128.8,128.6,127.8,127.2,126.7,126.6,125.7,122.1,119.7,119.3,117.5,109.8,52.9,50.0,45.8,37.8ppm.
example 14
The reaction equation is as follows:
Figure BDA0003917886310000151
1g (5 mmol) of the compound, 2a (7.5 mmol), iron bromide (0.5 mmol), chiral phosphoric acid (0.5 mmol) and
Figure BDA0003917886310000152
molecular sieves (1 g) were added to the reactor, p-xylene was added to the reactor in an amount of 100mL, and the mixture was stirred at 60 ℃ until the reaction was completed. After the reaction is finished, a crude product obtained by concentrating the reaction liquid by a rotary evaporator is subjected to column chromatography by using a mixed solution of dichloromethane and petroleum ether in a volume ratio of 4.
Nuclear magnetic data for R-3ga are as follows:
1 H NMR(500MHz,CDCl 3 )δ7.42(d,J=8.0Hz,1H),7.32(d,J=7.5Hz,2H),7.29-7.24(m,5H),7.21-7.14(m,2H),7.11(t,J=7.5Hz,1H),7.06(d,J=7.5Hz,2H),7.00(t,J=7.5Hz,1H),6.97(s,1H),4.92(t,J=7.5Hz,1H),3.71(s,3H),3.73(s,3H),3.66(dd,J=7.5,17.5Hz,1H),3.59(dd,J=8.0,17.0Hz,1H)ppm.
13 C NMR(125MHz,CDCl 3 )δ192.6,161.4,143.3,137.6,137.0,128.8,128.6,127.8,127.2,126.7,126.6,125.7,122.1,119.7,119.3,117.5,109.8,52.9,50.0,45.8,37.8ppm.
example 15
The reaction equation is as follows:
Figure BDA0003917886310000161
compound 1h (5 mmol), 2a (7.5 mmol), zirconium chloride (0.5 mmol), chiral phosphoric acid (0.5 mmol), silver acetate (0.5 mmol) and
Figure BDA0003917886310000162
molecular sieves (1 g) were added to the reactor, followed by addition of 100mL of methylene chloride and stirring at 0 ℃ until the reaction was complete. After the reaction is finished, a crude product obtained by concentrating the reaction solution by a rotary evaporator is subjected to column chromatography separation by using a mixed solution of dichloromethane and petroleum ether with the volume ratio of 4.
The nuclear magnetic data for S-3ha are as follows:
1 H NMR(500MHz,CDCl 3 )δ7.42(d,J=8.0Hz,1H),7.33(d,J=7.5Hz,2H),7.27-7.23(m,3H),7.19-7.15(m,2H),7.01(t,J=7.5Hz,1H),6.86(s,1H),5.07-4.99(m,1H),4.90(t,J=7.5Hz,1H),3.71(s,3H),3.64(dd,J=7.5,17.0Hz,1H),3.57(dd,J=8.0,17.0Hz,1H),1.26(d,J=6.5Hz,3H),1.23(d,J=6.5Hz,3H)ppm.
13 C NMR(125MHz,CDCl 3 )δ193.5,160.6,143.5,137.3,128.5,127.8,126.9,126.5,126.4,121.8,119.5,119.0,116.9,109.2,70.7,45.7,37.8,32.7,21.5,21.5ppm.
example 16
The reaction equation is as follows:
Figure BDA0003917886310000171
the compound was reacted with 1h (5 mmol), 2a (7.5 mmol), ferric bromide (0.5 mmol), chiral phosphoric acid (0.5 mmol) and
Figure BDA0003917886310000172
molecular sieves (1 g) were added to the reactor, followed by addition of 100mL of methylene chloride and stirring at 0 ℃ until the reaction was complete. After the reaction is finished, a crude product obtained by concentrating the reaction solution by a rotary evaporator is subjected to column chromatography separation by using a mixed solution of dichloromethane and petroleum ether with the volume ratio of 4.
The nuclear magnetic data for R-3ha are as follows:
1 H NMR(500MHz,CDCl 3 )δ7.42(d,J=8.0Hz,1H),7.33(d,J=7.5Hz,2H),7.27-7.23(m,3H),7.19-7.15(m,2H),7.01(t,J=7.5Hz,1H),6.86(s,1H),5.07-4.99(m,1H),4.90(t,J=7.5Hz,1H),3.71(s,3H),3.64(dd,J=7.5,17.0Hz,1H),3.57(dd,J=8.0,17.0Hz,1H),1.26(d,J=6.5Hz,3H),1.23(d,J=6.5Hz,3H)ppm.
13 C NMR(125MHz,CDCl 3 )δ193.5,160.6,143.5,137.3,128.5,127.8,126.9,126.5,126.4,121.8,119.5,119.0,116.9,109.2,70.7,45.7,37.8,32.7,21.5,21.5ppm.
as can be seen from the above examples, two enantiomers of chiral γ -indole- α -keto acid ester compounds can be selectively synthesized according to the present invention using different combinations of Lewis acids, chiral phosphoric acids, and silver salts.

Claims (6)

1. The asymmetric synthesis method of the chiral gamma-indole-alpha-keto acid ester compound is characterized in that two enantiomer structural formulas of the chiral gamma-indole-alpha-keto acid ester compound respectively have structures shown in a formula I and a formula II:
Figure FDA0003917886300000011
the method comprises the following steps: adding gamma-indole-beta, gamma-unsaturated-alpha-keto ester, hanster, lewis acid 1, lewis acid 2, chiral phosphoric acid, silver salt, additive and solvent into a reactor, stirring at a certain temperature until the reaction is finished, concentrating the reaction liquid by a rotary evaporator to obtain a crude product, and performing column chromatography separation to obtain the product. Wherein, gamma-indole-beta, gamma-unsaturated-alpha-keto ester, hans ester, lewis acid 1, chiral phosphoric acid, silver salt, additive and solvent are added to selectively obtain the chiral gamma-indole-alpha-keto ester compound with S configuration, and the chemical process is shown in a reaction formula III:
Figure FDA0003917886300000012
adding gamma-indole-beta, gamma-unsaturated-alpha-keto ester, hans ester, lewis acid 2, chiral phosphoric acid, additive and solvent to selectively obtain chiral gamma-indole-alpha-keto ester compounds with R configuration, wherein the chemical process is shown in a reaction formula IV:
Figure FDA0003917886300000013
wherein R is selected from any one of phenyl, substituted phenyl and thienyl, and the substituent of the substituted phenyl is any one of halogen atom, saturated alkyl, alkoxy, phenyl and trifluoromethyl;
R 1 any one selected from hydrogen atom, halogen atom, saturated alkyl group and alkoxy group;
R 2 any one selected from hydrogen atom, methyl and benzyl;
R 3 any one of methyl, ethyl, isopropyl and benzyl;
R 4 any one of methyl, ethyl, tertiary butyl and benzyl;
the Lewis acid 1 is selected from any one of zirconium fluoride, zirconium chloride and zirconium bromide;
the Lewis acid 2 is selected from any one of ferric chloride, ferric bromide and ferric trifluoromethanesulfonate;
the silver salt is selected from any one of silver carbonate, silver acetate, silver trifluoroacetate, silver pentafluoropropionate, silver trifluoromethanesulfonate, silver tetrafluoroborate and silver hexafluorophosphate;
the additive is selected from
Figure FDA0003917886300000021
Molecular sieve,
Figure FDA0003917886300000022
A molecular sieve,
Figure FDA0003917886300000023
Any one of molecular sieves;
the chiral phosphoric acid has a structure shown in formula V and formula VI:
Figure FDA0003917886300000024
wherein Ar is 1 The compound is selected from substituted phenyl, and the substituent of the substituted phenyl is any one of phenyl, pentafluorophenyl and 1-naphthyl; ar (Ar) 2 Selected from biphenyl.
2. The method according to claim 1, wherein the solvent is selected from the group consisting of dichloromethane, 1, 2-dichloroethane, diethyl ether, tetrahydrofuran, 1, 4-dioxane, ethyl acetate, toluene, and p-xylene.
3. The method of claim 1, wherein the molar ratio of the γ -indole- β, γ -unsaturated- α -keto ester, hans-ester, lewis acid 1, lewis acid 2, chiral phosphoric acid, silver salt is 1.0 (1.0-2.0): 0-0.2): 0.05-0.2): 0-0.2; the dosage of the additive is 100-300mg/mmol.
4. The process according to claim 1, wherein the reaction time is 6 to 18 hours.
5. The method according to claim 1, wherein the reaction temperature is 0 to 60 ℃.
6. The preparation method according to claim 1, wherein the column chromatography is performed using a mixed solution of dichloromethane and petroleum ether.
CN202211344626.5A 2022-10-31 2022-10-31 Asymmetric synthesis method of chiral gamma-indole-alpha-keto ester compound Active CN115611797B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211344626.5A CN115611797B (en) 2022-10-31 2022-10-31 Asymmetric synthesis method of chiral gamma-indole-alpha-keto ester compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211344626.5A CN115611797B (en) 2022-10-31 2022-10-31 Asymmetric synthesis method of chiral gamma-indole-alpha-keto ester compound

Publications (2)

Publication Number Publication Date
CN115611797A true CN115611797A (en) 2023-01-17
CN115611797B CN115611797B (en) 2024-01-19

Family

ID=84876796

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211344626.5A Active CN115611797B (en) 2022-10-31 2022-10-31 Asymmetric synthesis method of chiral gamma-indole-alpha-keto ester compound

Country Status (1)

Country Link
CN (1) CN115611797B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112778191A (en) * 2021-01-06 2021-05-11 青岛科技大学 Visible light mediated method for synthesizing allyl alcohol compound containing indole skeleton
CN112812122A (en) * 2020-12-31 2021-05-18 青岛科技大学 Method for selectively synthesizing beta-indole-alpha, beta-unsaturated carbonyl compound and pyrano [2,3-b ] indole
CN113788756A (en) * 2021-10-12 2021-12-14 青岛科技大学 Method for green synthesis of optically pure allyl alcohol compound by using diacid as catalyst
CN114478245A (en) * 2022-01-21 2022-05-13 青岛科技大学 Asymmetric synthesis method of chiral gamma-alkynyl-alpha-keto acid ester compound

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112812122A (en) * 2020-12-31 2021-05-18 青岛科技大学 Method for selectively synthesizing beta-indole-alpha, beta-unsaturated carbonyl compound and pyrano [2,3-b ] indole
CN112778191A (en) * 2021-01-06 2021-05-11 青岛科技大学 Visible light mediated method for synthesizing allyl alcohol compound containing indole skeleton
CN113788756A (en) * 2021-10-12 2021-12-14 青岛科技大学 Method for green synthesis of optically pure allyl alcohol compound by using diacid as catalyst
CN114478245A (en) * 2022-01-21 2022-05-13 青岛科技大学 Asymmetric synthesis method of chiral gamma-alkynyl-alpha-keto acid ester compound

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
MAN WANG等: ""Asymmetric Binary Acid Catalysis: Switchable Enantioselectivity in Enantioselective Conjugate Hydride Reduction"", ORGANIC LETTERS, vol. 25, no. 2, pages 373 - 377 *
MAN WANG等: ""Bioinspired cyclization of in situ generated γ-indolyl β, γ-unsaturated α-keto esters via an oxidative enamine process: facile approaches to pyrano[2, 3-b]indoles"", ORGANIC CHEMISTRY FRONTIERS, vol. 8, no. 22, pages 6337 - 6343 *
XU CHEN等: ""Boosting Chemical Stability, Catalytic Activity, and Enantioselectivity of Metal-Organic Frameworks for Batch and Flow Reactions"", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 139, no. 38, pages 13476 - 13482 *
YANLING LIU等: ""AgAsF6/Sm(OTf)3 Promoted Reversal of Enantioselectivity for the Asymmetric Friedel-Crafts Alkylations of Indoles with β, γ-Unsaturated α-Ketoesters"", ORGANIC LETTERS, vol. 12, no. 1, pages 180 - 183 *

Also Published As

Publication number Publication date
CN115611797B (en) 2024-01-19

Similar Documents

Publication Publication Date Title
CN107056795B (en) A kind of loop coil hydroxyindole pentamethylene and β-lactones compound synthesis method
CN112812122B (en) Method for selectively synthesizing beta-indole-alpha, beta-unsaturated carbonyl compound and pyrano [2,3-b ] indole
CN116253721B (en) N- (4-indolyl) -N' -alkyl imidazole salt and application thereof
CN115611797B (en) Asymmetric synthesis method of chiral gamma-indole-alpha-keto ester compound
CN114478245A (en) Asymmetric synthesis method of chiral gamma-alkynyl-alpha-keto acid ester compound
CN107915653B (en) Method for preparing amide by catalyzing ester and amine to react
CN111848480A (en) Method for synthesizing aryl difluoromethyl seleno ether from arylboronic acid and application thereof
CN115108937A (en) Synthesis method of alpha-azidoketone containing three-level stereocenter
CN111229312B (en) Solvent-free catalyst and preparation method and application thereof
CN112778191A (en) Visible light mediated method for synthesizing allyl alcohol compound containing indole skeleton
CN112279765B (en) Preparation method of chiral alpha-fluoroketone compound
CN114315536A (en) Synthesis method of axial chiral diarylethene compound
EP0592881B1 (en) Process for producing optically active gamma-hydroxyketones
Szechner Synthesis and absolute configuration of two diastereoisomeric (1R, 2S, 3R)-and (1S, 2S, 3R)-2-amino-1-(2-furyl)-1, 3-butandiols
CN111732552A (en) Method for synthesizing 1, 3-oxazole-2-thioketone by palladium catalysis
CN114436836B (en) Method for preparing (R) -3- (2-methoxy-5-methyl) phenyl-3-phenylpropionic acid methyl ester compound
CN114349725B (en) Method for synthesizing 3, 3-disubstituted phthalide
CN115353457B (en) Asymmetric carbonate and preparation method thereof
CN115304557B (en) Enamine derivative and preparation method thereof
CN112299996B (en) Synthesis method of chiral alpha-deuterated ketone
CN117659018A (en) Chiral C1 symmetrical imidazole-pyridine-imidazolidinone tridentate nitrogen ligand, synthesis and application thereof
CN117510381A (en) Allylamine compound and preparation method and application thereof
US8822696B2 (en) Ligand for asymmetric synthesis catalyst, and process for production of alpha-alkenyl cyclic compound using the same
CN117486772A (en) Preparation method of 1, 2-diselenide compound
CN117126077A (en) Method for synthesizing 4-aryl nitrile compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant